로딩 중…
지수 로딩 중…
Raphas Co., Ltd.
214260· KOSDAQ· Consumer Staples· Household & Personal Products
₩7,920-2.82%
2026-06-19
Price Chart
Raphas Co., Ltd.-53.71%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 70.67B KRW |
| Revenue | 30.69B KRW |
| Net Income | -1.22B KRW |
| Total Assets | 72.26B KRW |
| Net Assets | 29.85B KRW |
| Employees | 100 |
| Value | |
| P/B | 2.37x |
| P/S | 2.30x |
| FCF Yield | 0.70% |
| Profitability | |
| ROE | -4.10% |
| ROA | -1.69% |
| Op. Margin | -2.65% |
| Revenue Growth | -4.21% |
| Earnings Growth | -145.70% |
| Financial Health | |
| Debt Ratio | 242.07% |
| Total Debt | 41.36B KRW |
| FCF | 491.3M KRW |
| Cash | 9.15B KRW |
| Current Ratio | 0.83x |
| Performance | |
| 1Y Return | -53.71% |
| 1M Return | 2.86% |
| From 52W High | -55.73% |
| 1Y MDD | -67.90% |
| Trading | |
| Volume | 26,112 shares |
| Foreign Own. | 0.00% |
| Per Share | |
| EPS | -455 KRW |
| BPS | 3,272 KRW |
Company Info
Raphas, established in 2006 and headquartered in Gangseo-gu, Seoul, was listed on KOSDAQ as a technology growth company in 2019. It specializes in the research, development, manufacturing, and sales of soluble microneedle patches, a transdermal drug delivery technology. While current sales are primarily in cosmetic fields like beauty patches, the company is expanding its business into pharmaceuticals, vaccine patches, and medical devices. Its unique DEN technology allows for microneedle production in about 5 minutes using only room-temperature air circulation, without UV light, and offers flexible control over length and pattern without molds.